Reliable One‐Pot Automated Preparation of [ 11 C]SL25.1188 for Use in Clinical Imaging Studies
Journal of Labelled Compounds and Radiopharmaceuticals · 2026
DOI: 10.1002/jlcr.70035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, 2026. Verfasst von Hiroki Hashimoto und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology (QST)…. Hauptthemen laut MEDLINE: Carbon Radioisotopes, Radiopharmaceuticals, Isoxazoles, Radiochemistry. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japanese Ministry of Education and Japan Society for the Promotion of Science, Culture, Sports, Science, and Technology, Japan Agency for Medical Research and Development (AMED).
Abstract (Originalsprache)
We clinically investigated ( S )‐5‐methoxymethyl‐3‐[6‐(4,4,4‐trifluorobutoxy)benzo[ d ]isoxazol‐3‐yl]oxazolidin‐2‐[ 11 C]‐one ([ 11 C]SL25.1188) as a positron emission tomography tracer for imaging monoamine oxidase B. To perform clinical imaging studies at our institute, we established a routine method for preparing the [ 11 C]SL25.1188 injection using a one‐pot [ 11 C]CO 2 fixation method. We successfully prepared the [ 11 C]SL25.1188 injection using a 11 C‐labeling synthesizer and sterile isolator. The radiosynthesis time and decay‐corrected radiochemical yield based on [ 11 C]CO 2 were below 30 min and 49% ± 10% postirradiation ( n = 104), respectively. At the end of synthesis ( n = 104), the molar activity was 180 ± 57 GBq/μmol, and the radiochemical purity exceeded 99%. The results of [ 11 C]SL25.1188 injection complied fully with our in‐house quality control and quality assurance criteria, confirming a reliable supply of high‐quality [ 11 C]SL25.1188 formulation with adequate radioactivity for use in clinical imaging studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology (QST), Chiba, Japan.
- SHI Accelerator Service Ltd, Tokyo, Japan.
- Tokyo Nuclear Services Co. Ltd, Tokyo, Japan.
ORCID-Profile: Kazunori Kawamura, Ming-Rong Zhang
Förderung
- Japanese Ministry of Education and Japan Society for the Promotion of Science, Culture, Sports, Science, and Technology
- Japan Agency for Medical Research and Development (AMED)
Zitieren
APA
Hashimoto, H., Ohkubo, T., Tsukagoe, K., Fujishiro, T., Arashi, D., Sato, T., Seki, T., Kurihara, Y., Ogawa, M., Muto, M., Nengaki, N., Mori, W., Fujinaga, M., Kawamura, K., & Zhang, M. R. (2026). Reliable One‐Pot Automated Preparation of [ 11 C]SL25.1188 for Use in Clinical Imaging Studies. Journal of Labelled Compounds and Radiopharmaceuticals. https://doi.org/10.1002/jlcr.70035
Vancouver
Hashimoto H, Ohkubo T, Tsukagoe K, Fujishiro T, Arashi D, Sato T, et al. Reliable One‐Pot Automated Preparation of [ 11 C]SL25.1188 for Use in Clinical Imaging Studies. Journal of Labelled Compounds and Radiopharmaceuticals. 2026. doi:10.1002/jlcr.70035
BibTeX
@article{Hashimoto2026,
author = {Hashimoto, Hiroki and Ohkubo, Takayuki and Tsukagoe, Kaito and Fujishiro, Tomoya and Arashi, Daisuke and Sato, Tatsuto and Seki, Takeru and Kurihara, Yusuke and Ogawa, Masanao and Muto, Masatoshi and Nengaki, Nobuki and Mori, Wakana and Fujinaga, Masayuki and Kawamura, Kazunori and Zhang, Ming-Rong},
title = {Reliable One‐Pot Automated Preparation of [ 11 C]SL25.1188 for Use in Clinical Imaging Studies},
journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
year = {2026},
doi = {10.1002/jlcr.70035}
}
EUVIMED